You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hepatitis D, Chronic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Safety and Biomarkers of Bulevirtide Treatment in Chronic

Recruiting
  • Chronic Hepatitis D
  • Stockholm, Sweden
    Karolinska University Hospital, Department of Infectious Disease
Sep 27, 2023

Chronic Hepatitis D Infection Trial in Changchun (Hepalatide, Hepalatide Placebo)

Not yet recruiting
  • Chronic Hepatitis D Infection
  • Changchun, China
    The first hospital of Jilin University
Apr 22, 2023

Viral Hepatitis D Relapses Upon Discontinuation of Bulevertide

Recruiting
  • Chronic Hepatitis D
    • Moscow, Russian Federation
      Center of Target Therapy
    Nov 6, 2023

    Chronic Hepatitis D Infection Trial (Bulevirtide)

    Not yet recruiting
    • Chronic Hepatitis D Infection
    • Bulevirtide
    • (no location specified)
    Jan 30, 2023

    Hepatitis D Trial in Athens (Bulevirtide)

    Recruiting
    • Hepatitis D
    • Athens, Greece
      Department of Gastroenterology, Medical School of National & Kap
    Jun 28, 2023

    Hepatitis D, Chronic Trial in Auckland (VIR-2218, VIR-3434)

    Not yet recruiting
    • Hepatitis D, Chronic
    • Auckland, New Zealand
      Investigative Site
    Jul 12, 2022

    Hepatitis D, Chronic Trial in Israel, New Zealand, Pakistan (Peginterferon Lambda-1A)

    Completed
    Has Results
    • Hepatitis D, Chronic
    • Peginterferon Lambda-1A
    • Beersheba, Israel
    • +3 more
    Dec 20, 2022

    Complex of Carnitine Orotate and Biphenyl Dimethyl Dicarboxylate

    Not yet recruiting
    • Chronic Viral Hepatitis B With Delta-Agent
      • Esik, Almaty Region, Kazakhstan
      • +6 more
      Oct 3, 2023

      Chronic Delta Hepatitis Trial (lonafarnib, Ritonavir)

      Completed
      • Chronic Delta Hepatitis
      • (no location specified)
      Dec 12, 2022

      Chronic Hepatitis D Infection Trial (Bulevirtide)

      Not yet recruiting
      • Chronic Hepatitis D Infection
      • Bulevirtide
      • (no location specified)
      Mar 1, 2023

      Hepatitis D, Chronic Trial in Be'er Sheva, Auckland, Istanbul (Lonafarnib, Ritonavir)

      Recruiting
      • Hepatitis D, Chronic
      • Be'er Sheva, Israel
      • +2 more
      Jan 27, 2022

      Chronic Hepatitis B and Hepatitis D Co-infection Trial in Changchun (HH-003 20mg/kg, HH-003 3mg/kg)

      Active, not recruiting
      • Chronic Hepatitis B and Hepatitis D Co-infection
      • HH-003 20mg/kg
      • HH-003 3mg/kg
      • Changchun, Jilin, China
        First Hospital of Jilin University
      Dec 30, 2022

      Testing and Epidemiology of Delta Hepatitis

      Not yet recruiting
      • Chronic Hepatitis D Infection With Hepatitis B
        • Los Angeles, California
          Asian Pacific Liver Center
        Dec 20, 2021

        Bulevirtide Therapy in Chronic Hepatitis Delta in Italy

        Recruiting
        • Hepatitis D
        • Milan, MI, Italy
          Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Divis
        Nov 7, 2023

        Liver Disease, Hepatitis D Trial run by the NIDDK (Peg-interferon lambda, Lonafarnib, Ritonavir)

        Completed
        Has Results
        • Liver Disease
        • Hepatitis D
        • Peg-interferon lambda
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Dec 6, 2021

        Chronic Hepatitis b Trial in Guangzhou (Vitamin D)

        Completed
        • Chronic Hepatitis b
        • Vitamin D
        • Guangzhou, Guangdong, China
          Department of Infectious Diseases, The Third Affliated Hospital
        Mar 2, 2023

        Bulevirtide Therapy in HDV Chronic Hepatitis in Italy

        Completed
        • Hepatitis D
        • Milan, MI, Italy
          Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Divis
        Jul 24, 2023

        Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

        Terminated
        • Hepatitis B, Chronic
        • Hepatitis D
        • Chisinau, Republic Of Moldova, Moldova, Republic of
        • +1 more
        Nov 15, 2022

        Chronic Hepatitis Delta Virus Infection Trial (HH-003(20mg/kg), HH-003(10mg/kg), TAF)

        Not yet recruiting
        • Chronic Hepatitis Delta Virus Infection
        • HH-003(20mg/kg)
        • +2 more
        • (no location specified)
        May 7, 2023

        Chronic Hepatitis Delta Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Peginterferon

        Not yet recruiting
        • Chronic Hepatitis Delta
        • Peginterferon Lambda
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jul 25, 2023

        COVID-19 Vaccination and Prevalence of COVID-19 in Chronic Liver

        Not yet recruiting
        • Chronic or Recovered Hepatitis B
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Feb 2, 2023

          Bulevirtide in Patients With Chronic HBV/HDV Co-infection

          Recruiting
          • Hepatitis D, Chronic
          • Hepatitis B, Chronic
            • Lyon, France
              ZOULIM
            Aug 5, 2021

            Chronic Hepatitis B Infection, Chronic Hepatitis D Infection Trial in Taipei City, Taipei city, Taoyuan city (P1101 + Nivolumab

            Recruiting
            • Chronic Hepatitis B Infection
            • Chronic Hepatitis D Infection
            • P1101 + Nivolumab + Entecavir
            • Taipei City, Taiwan
            • +3 more
            Sep 15, 2021

            Burden of Hepatitis D Virus (HDV) Infection in Italy

            Recruiting
            • Chronic Hepatitis D
              • Bari, Italy
              • +35 more
              Feb 1, 2023

              Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)

              Not yet recruiting
              • Liver Cancer
              • Houston, Texas
                M D Anderson Cancer Center
              Feb 9, 2023